<code id='B7FAE036F2'></code><style id='B7FAE036F2'></style>
    • <acronym id='B7FAE036F2'></acronym>
      <center id='B7FAE036F2'><center id='B7FAE036F2'><tfoot id='B7FAE036F2'></tfoot></center><abbr id='B7FAE036F2'><dir id='B7FAE036F2'><tfoot id='B7FAE036F2'></tfoot><noframes id='B7FAE036F2'>

    • <optgroup id='B7FAE036F2'><strike id='B7FAE036F2'><sup id='B7FAE036F2'></sup></strike><code id='B7FAE036F2'></code></optgroup>
        1. <b id='B7FAE036F2'><label id='B7FAE036F2'><select id='B7FAE036F2'><dt id='B7FAE036F2'><span id='B7FAE036F2'></span></dt></select></label></b><u id='B7FAE036F2'></u>
          <i id='B7FAE036F2'><strike id='B7FAE036F2'><tt id='B7FAE036F2'><pre id='B7FAE036F2'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:8
          Cathy McMorris Rodgers -- health policy coverage from STAT
          Rep. Cathy McMorris Rodgers announced her plans to leave Congress at the end of 2024. Anna Moneymaker/Getty Images

          WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end of the year, she announced Thursday.

          It will be a major shakeup for a panel already ravaged by Republican retirements. Reps. Michael Burgess (R-Texas), Larry Bucshon (R-Ind.), Jeff Duncan (R-S.C.), Debbie Lesko (R-Ariz.), Greg Pence (R-Ind.) and Kelly Armstrong (R-N.D.) are all leaving at the end of this Congress, too.

          advertisement

          Under McMorris Rodgers, the panel led the way for House passage of a health care price transparency package that included the first major proposal to equalize payment between hospital outpatient departments and physician offices.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Faced with fears of OxyContin misuse, sales reps touted its safety
          Faced with fears of OxyContin misuse, sales reps touted its safety

          Photoillustration:STAT;photo:GettyImagesPIKEVILLE,Ky.—AyearandahalfaftertheopioidpainkillerOxyContin

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

          CourtesySanofiLONDON—Inabidtoexpanditspipelineofinflammation-targetingdrugs,SanofisaidTuesdayitwasac